Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify COVID-19 Treatments From Years to Months
08 juin 2021 08h00 HE
|
Scipher Medicine Corporation
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. WALTHAM, Mass., June 08, 2021 ...
LaunchWorks and Canadienzyme Collaboration Results in New Product for Diagnostic Testing
26 mai 2021 09h00 HE
|
LaunchWorks LLC
ANJOU, Quebec, May 26, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract development and manufacturing organization (CDMO) in molecular diagnostics, and Canadienzyme, a biotech spin-off company by...
LaunchWorks Scales up its Diagnostic Test Kit Manufacturing Capabilities
06 mai 2021 10h00 HE
|
LaunchWorks LLC
BEVERLY, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract and development organization serving the diagnostics industry, today announced that it has increased its filling capacity for...
LaunchWorks Opens New Facility in Anjou Canada
04 mai 2021 09h55 HE
|
LaunchWorks LLC
ANJOU, Quebec, May 04, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract development and manufacturing organization (CDMO) serving the diagnostics industry, today announced the opening of a new...
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
08 avr. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Point of Care Molecular Diagnostics Market to be Worth $2.32 billion by 2027- Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
01 avr. 2021 07h30 HE
|
Meticulous Market Research Pvt. Ltd.
London, April 01, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Point of Care Molecular Diagnostics Market by Product & Service (Assay, Analyzer, Software, Service),...
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
18 mars 2021 16h05 HE
|
Progenity, Inc.
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in December 2020 from a concurrent secondary equity offering and issuance of convertible notes, and $25M...
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
12 mars 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Announces $25 Million Private Placement
23 févr. 2021 07h45 HE
|
Progenity, Inc.
SAN DIEGO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing...
Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
17 févr. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...